Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-039440
Filing Date
2017-02-13
Accepted
2017-02-13 08:30:33
Documents
4
Period of Report
2017-03-01
Effectiveness Date
2017-02-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d338856ddef14a.htm DEF 14A 135210
2 GRAPHIC g338856g09k79.jpg GRAPHIC 27905
3 GRAPHIC g338856img001.jpg GRAPHIC 205669
4 GRAPHIC g338856img002.jpg GRAPHIC 100319
  Complete submission text file 0001193125-17-039440.txt   596492
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50865 | Film No.: 17596007
SIC: 2834 Pharmaceutical Preparations